JP2005501083A5 - - Google Patents

Download PDF

Info

Publication number
JP2005501083A5
JP2005501083A5 JP2003518654A JP2003518654A JP2005501083A5 JP 2005501083 A5 JP2005501083 A5 JP 2005501083A5 JP 2003518654 A JP2003518654 A JP 2003518654A JP 2003518654 A JP2003518654 A JP 2003518654A JP 2005501083 A5 JP2005501083 A5 JP 2005501083A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
group
cancer
carbonic anhydrase
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003518654A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005501083A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/025447 external-priority patent/WO2003013655A2/en
Publication of JP2005501083A publication Critical patent/JP2005501083A/ja
Publication of JP2005501083A5 publication Critical patent/JP2005501083A5/ja
Withdrawn legal-status Critical Current

Links

JP2003518654A 2001-08-10 2002-08-09 炭酸脱水酵素阻害剤 Withdrawn JP2005501083A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31156101P 2001-08-10 2001-08-10
PCT/US2002/025447 WO2003013655A2 (en) 2001-08-10 2002-08-09 Carbonic anhydrase inhibitors

Publications (2)

Publication Number Publication Date
JP2005501083A JP2005501083A (ja) 2005-01-13
JP2005501083A5 true JP2005501083A5 (enExample) 2005-12-22

Family

ID=23207450

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003518654A Withdrawn JP2005501083A (ja) 2001-08-10 2002-08-09 炭酸脱水酵素阻害剤

Country Status (7)

Country Link
EP (1) EP1414522A2 (enExample)
JP (1) JP2005501083A (enExample)
AU (1) AU2002331050A1 (enExample)
BR (1) BR0211836A (enExample)
CA (1) CA2456939A1 (enExample)
MX (1) MXPA04001268A (enExample)
WO (1) WO2003013655A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100594A1 (en) * 2001-08-10 2003-05-29 Pharmacia Corporation Carbonic anhydrase inhibitor
US7482354B2 (en) * 2003-05-22 2009-01-27 Nerviano Medical Sciences S.R.L. Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
LT5504B (lt) * 2006-08-02 2008-06-25 Biotechnologijos Institutas Benzimidazo[1,2-c][1,2,3]tiadiazolo sulfonamidai - karboanhidrazių slopikliai ir tarpiniai junginiai jiems gauti
US20120263714A1 (en) * 2009-10-21 2012-10-18 Bayer Intellectual Property Gmbh Substituted halophenoxybenzamide derivatives
JP6795525B2 (ja) * 2015-07-01 2020-12-02 シグナルケム・ライフサイエンシーズ・コーポレイションＳｉｇｎａｌｃｈｅｍ Ｌｉｆｅｓｃｉｅｎｃｅｓ Ｃｏｒｐｏｒａｔｉｏｎ 炭酸脱水酵素阻害剤としてのアリールスルホンアミド化合物およびその治療的使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2139281C1 (ru) * 1993-11-30 1999-10-10 Джи Ди Сирл энд Компани Пиразолилзамещенный бензолсульфонамид или его фармацевтически приемлемая соль, фармацевтическая композиция, способ лечения от воспаления или связанного с воспалением заболевания
JP3181190B2 (ja) * 1994-12-20 2001-07-03 日本たばこ産業株式会社 オキサゾール誘導体
US5944021A (en) * 1995-06-07 1999-08-31 Rodriguez; Victorio C. Therapeutic use of a carbonic anhydrase enzyme inhibitor for the treatment of brain edema
BR9708574A (pt) * 1996-04-12 1999-08-03 Searle & Co Derivados benzeno sulfonamida substituídos como pródrogas de inibidores cox-2
AU8026200A (en) * 1999-10-19 2001-04-30 Board Of Regents, The University Of Texas System Treatment of heart disease with cox-2 inhibitors

Similar Documents

Publication Publication Date Title
NZ509755A (en) Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia
KR100779285B1 (ko) 미세 자가-유화성 약학 조성물의 제조 방법
KR100765614B1 (ko) 유방염 및 이질환 치료용 분산성 제약 조성물
RU2325189C2 (ru) Способ и фармацевтическая композиция для доставки противовоспалительного средства
DE69733338D1 (de) Zubereitungen, enthaltend einen cyclooxygenase-2-inhibitor und einen leukotrien-b4-rezeptor-antagonisten
SI9720035B (sl) Substituirani benzensulfonamidni derivati kot predzdravila COX-2 inhibitorjev
JP2004526765A5 (enExample)
ES2252448T3 (es) Composicion parenteral reconstituible que contiene un inhibidor de la cox-2.
US20080153894A1 (en) Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
JP2005539023A5 (enExample)
KR20040012761A (ko) 안정화된 경구 약학적 조성물
US20030105141A1 (en) Finely self-emulsifiable pharmaceutical composition
AU2002305175A1 (en) Orally deliverable pharmaceutical composition comprising a drug of low water solubility (COX-2 inhibitor), a solvent, a fatty acid and an organic amine
JP2005501850A5 (enExample)
JP2005501083A5 (enExample)
US20040033938A1 (en) Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
Check et al. The use of sympathomimetic amines for the treatment of severe constipation refractory to conventional therapy
EP1526847A2 (en) Pharmaceutical dosage form comprising a sulfite compound
US20040105884A1 (en) Pharmaceutical dosage form comprising a sulfite compound
US20060111345A1 (en) Pharmaceutical compositions comprising a selective COX-2 inhibitor and a diuretic
JP2007500692A (ja) 乳房炎及び耳障害を治療するための分散性医薬組成物
Greene Whales and Dolphins
KR20210090367A (ko) 항암제에 의해 유도되는 이질통의 예방 또는 치료용 조성물 및 이를 이용한 치료방법
RU2024111332A (ru) Ресметиром для уменьшения объема печени
JP2001521889A5 (enExample)